Dystonia - complex
Gene: OPA3
Neuroophthalmologic syndrome consisting of early-onset bilateral optic atrophy and later-onset spasticity, extrapyramidal dysfunction (including dystonia and chorea), and cognitive deficit. Urinary excretion of 3-methylglutaconic acid and of 3-methylglutaric acid is increased. Multiple families reported.Created: 9 Sep 2020, 5:12 a.m. | Last Modified: 9 Sep 2020, 5:12 a.m.
Panel Version: 0.123
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
3-methylglutaconic aciduria, type III, MIM# 258501
Publications
Costeff syndrome, most patients are Iraqi-Jewish ancestry
Sources: Expert listCreated: 9 Sep 2020, 2:40 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
developmental delay, hypotonia; dystonia and chorea; ataxia, optic atrophy; spastic paraplegia
Publications
Gene: opa3 has been classified as Green List (High Evidence).
Phenotypes for gene: OPA3 were changed from developmental delay, hypotonia; dystonia and chorea; ataxia, optic atrophy; spastic paraplegia to 3-methylglutaconic aciduria, type III, MIM# 258501; developmental delay, hypotonia; dystonia and chorea; ataxia, optic atrophy; spastic paraplegia
Publications for gene: OPA3 were set to PMID: 20301646
Gene: opa3 has been classified as Green List (High Evidence).
gene: OPA3 was added gene: OPA3 was added to Dystonia - complex. Sources: Expert list Mode of inheritance for gene: OPA3 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: OPA3 were set to PMID: 20301646 Phenotypes for gene: OPA3 were set to developmental delay, hypotonia; dystonia and chorea; ataxia, optic atrophy; spastic paraplegia